|
|
||||||||||||||
|
|
|||||||||||||||
Therapeutics |
Clinical impact ratings GP/FP/Primary care






Geriatrics 





Haematology 





Key Words: vitamin B12 deficiency
| The first 150 words of the full text of this article appear below. |
METHODS
Data sources:
Cochrane Library (Issue 1, 2005), Medline (to Dec 2004), EMBASE/Excerpta Medica (to Dec 2004), Lilacs (to Dec 2004), National Research Register (UK), Current Controlled Trials, National Institutes of Health (USA), bibliographies of relevant papers, authors of relevant studies, experts in the field, and vitamin B12 manufacturers.
Study selection and assessment:
randomised controlled trials (RCTs) that compared the effects of oral and IM vitamin B12 in patients with low serum vitamin B12 concentrations who met criteria for replacement therapy (cut point of 180 pmol/l [240 pg/ml] for vitamin B12 deficiency). Studies of patients with primary folate deficiency or end stage renal disease or on haemodialysis, as well as studies of vitamin B12 for prevention of cardiovascular disease, were excluded. 2 researchers independently assessed the methodological quality of individual studies based on publication bias, selection bias, performance bias, attrition bias, and detection bias.
Outcomes:
serum vitamin B12 concentrations and clinical
Andrea K Bial, MD
University of Chicago
Chicago, Illinois, USA
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |